β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Epidemiology

Pathology

Internal Medicine

Surgery

Show all topics

DOI

10.1016/s0140-6736(18)31875-0